United States · FDA National Drug Code directory
Divalproex sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-594_895f2839-f689-4d0e-9d46-397f48dfa125
- Product NDC
- 65862-594
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- Divalproex sodium
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140602
- Source listing expiry
- 20271231
Source-listed ingredients
- DIVALPROEX SODIUM — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-594-01) · 65862-594-01
- 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-594-05) · 65862-594-05
- 10 BLISTER PACK in 1 CARTON (65862-594-10) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 65862-594-10
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-594-60) · 65862-594-60
- 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-594-99) · 65862-594-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →